Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Spero Therapeutics Inc (SPRO)

Spero Therapeutics Inc (SPRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Spero Therapeutics to Report Third Quarter 2024 Financial Results and Provide Business Update on Thursday, November 14, 2024

SPRO : 1.3200 (+0.76%)
Spero Therapeutics Announces SPR720 Phase 2a Interim Results and Provides a Business Update

SPRO : 1.3200 (+0.76%)
Spero Therapeutics Announces Presentation of SPR719 (Active Moiety of SPR720) In Vitro Data Demonstrating Low Propensity for the Development of Resistance at IDWeek 2024

SPRO : 1.3200 (+0.76%)
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Spero Therapeutics, Inc. (NASDAQ: SPRO) for Potential Breaches of Fiduciary Duty By Its Board of Directors

/PRNewswire/ -- Purcell & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of...

SPRO : 1.3200 (+0.76%)
Pre-Market Brief: Stocks Mixed as Risk-off Rout Continues

December S&P 500 futures (ESZ22) are trending down -0.17% this morning after three major US benchmark indices ended the previous week at 3-month lows as fears grew that raising interest rates to combat...

ESZ22 : 3,871.47s (-0.66%)
SPRO : 1.3200 (+0.76%)
BUD : 57.28 (-0.93%)
RELI : 1.93 (-6.76%)
SONX : 0.0250 (-8.42%)
ASML : 669.47 (-1.14%)
GOGL : 11.82 (+0.34%)
Markets Today: Stocks Extend This Week’s Plunge on Recession Fears

Morning Markets December S&P 500 futures (ESZ22 ) this morning are down by -1.21% at a 2-month low. Stock indexes this morning are extending this week’s sell-off on concern that the Fed’s resolve to...

ESZ24 : 6,025.25s (+0.36%)
COST : 943.80 (+3.27%)
AMD : 147.95 (-1.25%)
FDX : 286.28 (+1.08%)
ACN : 355.53 (-1.44%)
DVN : 38.87 (-0.05%)
FANG : 181.88 (+0.16%)
XOM : 121.11 (-0.03%)
COP : 111.59 (-0.03%)
HAL : 29.23 (-1.08%)
OXY : 50.53 (-1.33%)
MRO : 28.50 (-0.18%)
Pre-Market Brief: Stocks Lower as Post-Fed Stumble Continues

December S&P 500 futures (ESZ22) are trending down -0.58% this morning after three major US benchmark indices ended in the red for a third straight trading session as investors reacted to the Federal Reserve's...

ESZ22 : 3,871.47s (-0.66%)
SPPI : 1.0300 (unch)
COST : 943.80 (+3.27%)
TTOO : 0.5799 (-18.52%)
SPRO : 1.3200 (+0.76%)
CANO : 2.30 (-2.13%)
HUM : 288.12 (+0.13%)
CVS : 55.54 (-2.68%)
Spero Therapeutics (NASDAQ: SPRO) Enters into Exclusive Licensing Agreement with GSK (NYSE: GSK) for the Commercialization of Tebipenem HBr

Spero Therapeutics, Inc. (NASDAQ: SPRO) is engaged as a clinical-stage biopharmaceutical company, which is focused on the research, development and

SPRO : 1.3200 (+0.76%)
GSK : 36.29 (-1.01%)
Micro Cap Up Over +100% In Premarket

A Massachusetts-based %Biotech firm is grabbing the attention of traders across the board during Thursday’s premarket after it was announced that the company has entered into an exclusive license agreement...

GSK : 36.29 (-1.01%)
SPRO : 1.3200 (+0.76%)
Pre-Market Brief: Stocks Mixed as Fed Signals More Sharp Rate Hikes

December S&P 500 futures (ESZ22) are trending up +0.49% this morning after three major US benchmark indices jolted up and down before plunging in the final 30 minutes of trading to close Wednesday in the...

ESZ22 : 3,871.47s (-0.66%)
SPRO : 1.3200 (+0.76%)
LLY : 831.54 (+4.27%)
CRM : 321.95 (+3.59%)
META : 589.34 (-0.40%)
TCOM : 65.48 (-4.31%)
NVAX : 8.91 (-2.94%)

Barchart Exclusives

3 Best Dividend-growth Stocks Soon To Be Crowned Kings
These three quality companies represent an excellent opportunity for long-term income generation. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar